Literature DB >> 7639081

[Protective effects of salvianolic acid A against impairment of memory induced by cerebral ischemia-reperfusion in mice].

G H Du1, J T Zhang.   

Abstract

In the present experiments, an impairment of memory model was made by cerebral ischemia-reperefusion in mice. Sal A at the dosage of 3 and 10 mg.kg-1 i.v. was shown to improve the impairment of memory function induced by cerebral ischemia-reperefusion in step down and step through tests. In these tests, the number of errors of Sal A treated group was less and the latency was longer than that of control group. Meanwhile, Sal A 3 and 10 mg.kg-1 i.v. was found to reduce the MDA contents in the cortex, hippocampus and striatum of cerebral ischemia-reperfused rats in vivo. Sal A 10-100 nmol.L-1 was shown to inhibit the brain lipid-peroxidation and scavenge the free hydroxyl radical in vitro. These results indicate that the antagonistic effects of Sal A on impairment of learning and memory caused by cerebral ischemia-reperefusion may be related with its anti-oxidant activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639081

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  1 in total

1.  Salvianolic acid A, a polyphenolic derivative from Salvia miltiorrhiza bunge, as a multifunctional agent for the treatment of Alzheimer's disease.

Authors:  Ying Ying Cao; Ling Wang; Hu Ge; Xi Lin Lu; Zhong Pei; Qiong Gu; Jun Xu
Journal:  Mol Divers       Date:  2013-05-24       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.